MPG.eBooks - Search Results - "Common drug review"

181

Pharmacoeconomic review report: Migalastat (Galafold) (Amicus therapeutics)

Published 2018

CADTH

“...CADTH common drug review...”

Read Now

182

Pharmacoeconomic review report: Glecaprevir / pibrentasvir (Maviret) (AbbVie corporation)

Published 2018

CADTH

“...CADTH common drug review...”

Read Now

183

Pharmacoeconomic review report: Ixekizumab (Taltz)

Published 2017

CADTH

“...CADTH common drug review...”

Read Now

184

Pharmacoeconomic review report: Omalizumab (Xolair)

Published 2017

CADTH

“...CADTH common drug review...”

Read Now

185

Pharmacoeconomic review report: Empagliflozin (Jardiance)

Published 2015

CADTH

“...CADTH common drug review...”

Read Now

186

Pharmacoeconomic review report: Sapropterin dihydrochloride (Kuvan)

Published 2017

Canadian Agency for Drugs and Technologies in Health

“...CADTH common drug review...”

Read Now

187

Pharmacoeconomic review report: Ivabradine hydrochloride (Lancora)

Published 2017

Canadian Agency for Drugs and Technologies in Health

“...CADTH common drug review...”

Read Now

188

Pharmacoeconomic review report: Tocilizumab (Actemra) (Hoffman-La Roche Limited)

Published 2018

Canadian Agency for Drugs and Technologies in Health

“...CADTH common drug review...”

Read Now

189

Pharmacoeconomic review report: Sofosbuvir/Velpatasvir/Voxilaprevir (Vosevi) (Gilead Sciences Canada, Inc.)

Published 2018

Canadian Agency for Drugs and Technologies in Health

“...CADTH common drug review...”

Read Now

190

Pharmacoeconomic review report: Nusinersen (Spinraza) (Biogen Canada Inc.)

Published 2018

Canadian Agency for Drugs and Technologies in Health

“...CADTH common drug review...”

Read Now

191

Pharmacoeconomic review report: Dolutegravir (Tivicay)

Published 2014

Canadian Agency for Drugs and Technologies in Health

“...CADTH common drug review...”

Read Now

192

Pharmacoeconomic review report: Insulin degludec (Tresiba) (Novo Nordisk Canada Inc.)

Published 2017

CADTH

“...CADTH common drug review...”

Read Now

193

Pharmacoeconomic review report: Ocrelizumab (Ocrevus) (Hoffmann-La roche limited)

Published 2018

Canadian Agency for Drugs and Technologies in Health

“...CADTH common drug review...”

Read Now

194

Pharmacoeconomic review report: Ocrelizumab (Ocrevus) (Hoffmann-La roche limited)

Published 2017

CADTH

“...CADTH common drug review...”

Read Now

195

Pharmacoeconomic review report: Sarilumab (Kevzara)

Published 2017

CADTH

“...CADTH common drug review...”

Read Now

196

Pharmacoeconomic review report: Nitisinone (MDK-Nitisinone) (MendeliKABS inc.)

Published 2018

Canadian Agency for Drugs and Technologies in Health

“...CADTH common drug review...”

Read Now

197

Pharmacoeconomic review report: Apomorphine (Movapo) (Paladin Labs, Inc.)

Published 2018

Canadian Agency for Drugs and Technologies in Health

“...CADTH common drug review...”

Read Now

198

Pharmacoeconomic review report: Cerliponase Alfa (Brineura) (BioMarin Pharmaceutical (Canada) Inc.) : indication: for the treatment of neuronal ceroid lipofuscinosis type 2 (CLN2)...

Published 2019

CADTH

“...CADTH common drug review...”

Read Now

199

Clinical review report: Doravirine (Pifeltro) (Merck Canada Inc.) : indication: Doravirine (Pifeltro) is indicated, in combination with other antiretroviral medicinal products, for...

Published 2019

CADTH

“...CADTH common drug review...”

Read Now

200

Pharmacoeconomic review report: Telotristat ethyl (Xermelo) : (Ipsen Biopharmaceuticals Canada Inc.)

Published 2019

Canadian Agency for Drugs and Technologies in Health

“...CADTH common drug review...”

Narrow Search